Literature DB >> 17493528

Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?

Tobias Deuse1, Sonja Schrepfer, Hermann Reichenspurner, Grant Hoyt, Michael P Fischbein, Robert C Robbins, Marc P Pelletier.   

Abstract

BACKGROUND: Different animal models have been developed to study the pathogenesis and treatment of obliterative airway disease (OAD). Here we describe the techniques of heterotopic and orthotopic tracheal transplantations in the rat, comparing the kinetics of systemic host immune response and of histopathologic OAD development.
METHODS: Heterotopic and orthotopic tracheal transplantations were performed in both allogeneic (Brown Norway-to-Lewis) and syngeneic (Lewis-to-Lewis) models. Grafts were harvested after 7, 30, and 60 days post-transplant for histologic evaluation and analysis of host cellular and humoral response.
RESULTS: Syngeneic tracheal grafts did not develop luminal obliteration and were morphologically indistinguishable from native tracheas. In heterotopic allografts, airway epithelium was rapidly destroyed and OAD progressed with complete luminal occlusion by 30 days. Orthotopic allografts showed enhanced early infiltration (1298+/-45 vs. 674+/-75 cells/high power field, p<0.001) with concomitant greater day 7 luminal narrowing (45+/-6% vs. 14+/-3%, p<0.001). In this model, donor-type BN epithelium (62+/-17%, 21+/-19%, and 1+/-1% on days 7, 30, and 60) was gradually replaced by recipient-type epithelial cells (2+/-4%, 70+/-22%, and 98+/-2%). OAD developed with circular orientation of cells and connective tissue fibers to 45+/-6% obliteration by day 60. Cellular host response, as determined by IFN-gamma-ELISPOT assay (548+/-132 vs. 402+/-197 spots, p=0.046) and anti-donor alloreactive IgM antibody production (2827+/-148 vs. 1565+/-393 mean channel fluorescence, p<0.001) were significantly stronger in rats bearing orthotopic vs. heterotopic allografts.
CONCLUSIONS: The orthotopic tracheal transplantation model may be more representative of OAD found in human lung transplant recipients and we therefore encourage the wider use of this model.

Entities:  

Mesh:

Year:  2007        PMID: 17493528     DOI: 10.1016/j.trim.2007.01.009

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  5 in total

1.  CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliteration.

Authors:  P D Shah; E E West; A B Whitlock; J B Orens; J F McDyer
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

2.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

Review 3.  Adverse effects of immunosuppressant drugs upon airway epithelial cell and mucociliary clearance: implications for lung transplant recipients.

Authors:  Rogerio Pazetti; Paulo Manuel Pêgo-Fernandes; Fabio Biscegli Jatene
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

4.  Heterotopic and orthotopic tracheal transplantation in mice used as models to study the development of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Karis R Tang-Quan; Robert C Robbins; Hermann Reichenspurner; Sonja Schrepfer
Journal:  J Vis Exp       Date:  2010-01-20       Impact factor: 1.355

5.  The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model.

Authors:  Yukiko Tando; Chiharu Ota; Mitsuhiro Yamada; Satoshi Kamata; Mutsuo Yamaya; Kuniyuki Kano; Shinichi Okudaira; Junken Aoki; Hiroshi Kubo
Journal:  Transplant Direct       Date:  2015-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.